- MediWound Announces €16.25 Million Funding from the European Innovation Council Accelerator Program
- MediWound Announces $25 Million Strategic Private Placement Financing
- MediWound Reports First Quarter 2024 Financial Results and Provides Company Update
- MediWound to Report First Quarter 2024 Financial Results
- MediWound to Present New Data from EscharEx® Phase II Studies at Three Leading Wound Care Conferences
- MediWound Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
- MediWound to Report Fourth Quarter and Full Year 2023 Financial Results
- MediWound Announces Positive Results in Head-to-Head Comparison of EscharEx® vs. SANTYL® within the ChronEx Phase II Randomized Controlled Study
- MediWound to Participate in Two Upcoming Investor Conferences
- MediWound Announces that FDA has Accepted for Review the Supplement to the NexoBrid BLA to Include Pediatric Patients with Severe Thermal Burns
More ▼
Key statistics
As of last trade Mediwound Ltd (M8W:DEU) traded at 18.30, -10.29% below its 52-week high of 20.40, set on Jul 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 18.10 |
---|---|
High | 18.30 |
Low | 17.80 |
Bid | 17.50 |
Offer | 18.40 |
Previous close | 18.20 |
Average volume | 246.50 |
---|---|
Shares outstanding | 9.28m |
Free float | 6.84m |
P/E (TTM) | -- |
Market cap | 181.31m USD |
EPS (TTM) | -1.38 USD |
Data delayed at least 15 minutes, as of Jul 24 2024.
More ▼